RE:Management FailureTP, .... best to wait out Aducanumab to gain acceptance by FDA to prove that the beta-amyloid theory of Alzheimer's disease is still a viable working hypothesis, paving the way for a more targeted therapies PMN has to offer. Perhaps, this is what management is waiting for.
jmo
G1945V